Shanghai Kangchen Bioengineering Co., Ltd.
PrivateLast Round
Series C
Extension
Jan 1, 2023
Total Funding Raised
$30.91M
Company Overview
Shanghai Kangchen Bioengineering Co., Ltd. (doing business as Aksomics) is a biotechnology company that provides technical services for life science research, including microarray analysis, sequencing, and proteomics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Kangchen Bioengineering Co., Ltd. Comparables
Compare Shanghai Kangchen Bioengineering Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arraystar Inc. | 85% | |
| Biomarker Technologies | 80% | |
| LC Sciences, LLC | 79% |
Shanghai Kangchen Bioengineering Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jan 1, 2023 | ||||
| M&A | Jan 1, 2023 | ||||
| Series C | Sep 1, 2022 | ||||
| Series B | Aug 16, 2021 | ||||
| Series A | Mar 1, 2020 |
Shanghai Kangchen Bioengineering Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 鹊山资本 | Series B |
| Beijing Taikang Investment Management Co., Ltd. | Series B |
| Longwater Investment | Series B |
| Shenzhen Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2023
Completed a Series C Extension funding round.
- Mar 1, 2020
Raised Series A round with Shenzhen Capital Group
Shanghai Kangchen Bioengineering Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Kangchen Bioengineering Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Kangchen Bioengineering Co., Ltd. a public or private company?
Shanghai Kangchen Bioengineering Co., Ltd. is a private company.
What is the current stock price of Shanghai Kangchen Bioengineering Co., Ltd.?
Shanghai Kangchen Bioengineering Co., Ltd. is a private company with no public stock price. Caplight tracks Shanghai Kangchen Bioengineering Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Shanghai Kangchen Bioengineering Co., Ltd. worth (valuation)?
Valuation information for Shanghai Kangchen Bioengineering Co., Ltd. is not publicly available.
Can I buy Shanghai Kangchen Bioengineering Co., Ltd. stock?
Shanghai Kangchen Bioengineering Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Kangchen Bioengineering Co., Ltd.'s last funding round?
Shanghai Kangchen Bioengineering Co., Ltd.'s most recent funding round was Series C Extension on January 1, 2023.
Who are the main investors in Shanghai Kangchen Bioengineering Co., Ltd.?
Key investors in Shanghai Kangchen Bioengineering Co., Ltd. include Longwater Investment.
Will Shanghai Kangchen Bioengineering Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Kangchen Bioengineering Co., Ltd..
How can I track Shanghai Kangchen Bioengineering Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Kangchen Bioengineering Co., Ltd.'s secondary market activity and sign up for updates.